This inventor holds 2 USPTO granted patents and 13 published patent applications. Top assignees: Hoffmann-La Roche Inc., Roche Glycart Ag. Active years: 2024-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024-2026
Title: Christian Klein - Innovator in Antibody Technology
Introduction
Christian Klein is a notable inventor based in Weilheim, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies that target specific proteins associated with diseases.
Latest Patents
Christian Klein holds a patent for "Antibodies binding to HLA-A2/WT1." This invention relates to antibodies that bind to HLA-A2/WT1, including bispecific antigen-binding molecules designed for activating T cells. The patent also encompasses polynucleotides encoding such antibodies, as well as vectors and host cells that contain these polynucleotides. Furthermore, the invention outlines methods for producing these antibodies and their applications in disease treatment.
Career Highlights
Christian Klein is currently employed at Hoffmann-La Roche Inc., a leading company in the pharmaceutical and biotechnology sectors. His work focuses on innovative solutions that enhance therapeutic options for patients.
Collaborations
Christian collaborates with esteemed colleagues, including Joerg Benz and Stefan Klostermann, who contribute to the advancement of research and development in their field.
Conclusion
Christian Klein's work in antibody technology exemplifies the innovative spirit of modern biotechnology. His contributions are paving the way for new treatments and therapies that can significantly impact patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile